EFFICACY OF SUPRASPINATUS NERVE APPROACH THROUGH CORTICOSTEROID ADMINISTRATION VERSUS PULSED RADIOFREQUENCY IN CHRONIC SHOULDER PAIN. DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL.

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519892-24-00

Enrollment

Registered

2025-01-15

Start date

Unknown

Completion date

Unknown

Last updated

2025-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic shoulder pain

Brief summary

The SPADI (Shoulder Pain and Disability Index) is a quality-of-life questionnaire designed to evaluate pain and disability related to shoulder pathology.

Detailed description

Demographics, Comorbidity, Visual Analog Scale (VAS), Numerical Verbal Scale (NVS), Range of Motion, Amount of Analgesics Administered, Hospital Anxiety and Depression Scale (HAD), EuroQol 5D (EQ-5D), Medical Outcomes Study Sleep Scale (MOS), Satisfaction Assessment

Interventions

DRUGTRIGON DEPOT 40 mg/ml suspensión inyectable.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
The SPADI (Shoulder Pain and Disability Index) is a quality-of-life questionnaire designed to evaluate pain and disability related to shoulder pathology.	—

Secondary

Measure	Time frame
Demographics, Comorbidity, Visual Analog Scale (VAS), Numerical Verbal Scale (NVS), Range of Motion, Amount of Analgesics Administered, Hospital Anxiety and Depression Scale (HAD), EuroQol 5D (EQ-5D), Medical Outcomes Study Sleep Scale (MOS), Satisfaction Assessment	—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026